Graphene-based materials as nanoplatforms for antiviral therapy and prophylaxis

Introduction The dramatic effects caused by viral diseases have prompted the search for effective therapeutic and preventive agents. In this context, 2D graphene-based nanomaterials (GBNs), have shown great potential for antiviral therapy, enabling the functionalization and/or or decoration with biomolecules, metals and polymers, able to improve their interaction with viral nanoparticles.